Alessandro Rambaldi

City:

Bergamo

Country:

Italy

Published Applications:

Last publication date:

2022-06-02

Top Assignees for applications by Alessandro Rambaldi

The entities that hold a legal rights for patent applications filed by inventor Rambaldi Alessandro:

ITALFARMACO S.P.A. 1 Milano, Italy
CONSIGLIO NAZIONALE DELLE RICHERCHE 1 Roma, Italy
AZIENDA OSPEDALIERA OSPEDALI RIUNITI DI BERGAMO 1 Bergamo, Italy
HUMANITAS MIRASOLE S.p.A. 1 Rozzano, Italy
ITALFARMACO SPA 1 Milan, Italy

Recent patent applications by Rambaldi Alessandro

Alessandro Rambaldi from Bergamo, IT has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2022-06-02

US20220168343A1

Human necessities

CANCER IMMUNOTHERAPY USING COMBINATIONS OF CELLS EXPRESSING CHIMERIC ANTIGEN RECEPTORS AND MONOCLONAL ANTIBODIES

#2 | 2021-05-06

US20210128512A1

Human necessities

USE OF HISTONE DEACETYLASE INHIBITORS FOR THE CARE OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE SYNDROMES

#3 | 2017-02-23

US20170049740A1

Human necessities

USE OF HISTONE DEACETYLASE INHIBITORS FOR THE CARE OF PHILADELPHIA-NEGATIVE MYELOPROLIFERATIVE SYNDROMES

#4 | 2014-02-06

US20140039059A1

Human necessities

Use of histone deacetylase inhibitors for the care of philadelphia-negative myeloproliferative syndromes

#5 | 2012-01-12

US20120009608A1

Physics

BIOMARKER FOR THE MONITORING AND PROGNOSIS OF CHRONIC MYELOPROLIFERATIVE DISORDERS

#6 | 2011-12-01

US20110294892A1

Human necessities

Use of histone deacetylase inhibitors for the care of Philadephia-negative myeloproliferative syndromes

#7 | 2007-01-18

US20070014785A1

Chemistry; metallurgy

Use of antibodies against CD20 for the treatment of the graft versus host disease

InventorID:

642608 ⎘